A Study of Genetic Variation Influencing Pain and Response to Opioid Medications
Withdrawn before enrolling
Conditions studied: Pain
In brief
The investigators will be collecting saliva DNA samples from chronic back pain patients. The investigators hope to find candidate genes associated with response to opioid medication by correlating molecular genetics data with pain measurement and opioid responsiveness data including opioid hyperalgesia and opioid analgesic tolerance.
Key facts
- Study ID
- NCT01293994
- Run by
- Stanford University
- People needed
- 0
- Starts
- 2009-02-01
- Expected to finish
- 2012-12-01
- Last updated by the study team
- 2016-11-22
Who can join
Age: 18 and older, up to 71. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patient, aged 18-71
- Recipient of chronic opioid therapy
- Patient is able to produce a saliva sample
- If a past study participant, patient will have agreed to be contacted for future studies.
You may not qualify if…
- a. not meeting inclusion criteria
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.